These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 24814877)

  • 1. Cost-of-illness studies of diabetes mellitus: a systematic review.
    Ng CS; Lee JY; Toh MP; Ko Y
    Diabetes Res Clin Pract; 2014 Aug; 105(2):151-63. PubMed ID: 24814877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of diabetes mellitus in Africa: a systematic review of existing literature.
    Mutyambizi C; Pavlova M; Chola L; Hongoro C; Groot W
    Global Health; 2018 Jan; 14(1):3. PubMed ID: 29338746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
    Javanbakht M; Mashayekhi A; Baradaran HR; Haghdoost A; Afshin A
    PLoS One; 2015; 10(7):e0132505. PubMed ID: 26200913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.
    Afroz A; Alramadan MJ; Hossain MN; Romero L; Alam K; Magliano DJ; Billah B
    BMC Health Serv Res; 2018 Dec; 18(1):972. PubMed ID: 30558591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of diabetes in Latin America and the Caribbean.
    Barceló A; Aedo C; Rajpathak S; Robles S
    Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-of-illness studies in diabetes mellitus.
    Ettaro L; Songer TJ; Zhang P; Engelgau MM
    Pharmacoeconomics; 2004; 22(3):149-64. PubMed ID: 14871163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current total economic burden of diabetes mellitus in the Netherlands.
    Peters ML; Huisman EL; Schoonen M; Wolffenbuttel BHR
    Neth J Med; 2017 Sep; 75(7):281-297. PubMed ID: 28956787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.
    Barcelo A; Arredondo A; Gordillo-Tobar A; Segovia J; Qiang A
    J Glob Health; 2017 Dec; 7(2):020410. PubMed ID: 29163935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The direct and indirect costs associated with endometriosis: a systematic literature review.
    Soliman AM; Yang H; Du EX; Kelley C; Winkel C
    Hum Reprod; 2016 Apr; 31(4):712-22. PubMed ID: 26851604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Direct and indirect diabetes costs in the world].
    Logminiene Z; Norkus A; Valius L
    Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative estimates of the financial burden to the UK health system of hospital care for people with and without diabetes in the year before death.
    Currie CJ; Morgan CL; Dixon S; McEwan P; Marchant N; Bearne A; Sharplin P; Peters JR
    Diabetes Res Clin Pract; 2004 Sep; 65(3):267-74. PubMed ID: 15331207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Burden of Psoriasis in the United States: A Systematic Review.
    Brezinski EA; Dhillon JS; Armstrong AW
    JAMA Dermatol; 2015 Jun; 151(6):651-8. PubMed ID: 25565304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review.
    Robinson LS; Sarkies M; Brown T; O'Brien L
    Injury; 2016 Dec; 47(12):2614-2626. PubMed ID: 27751502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of illness of diabetes mellitus in Indonesia: a systematic review.
    Patty YFPP; Mufarrihah ; Nita Y
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):285-295. PubMed ID: 34214313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach.
    Marcellusi A; Viti R; Mecozzi A; Mennini FS
    Eur J Health Econ; 2016 Mar; 17(2):139-47. PubMed ID: 25427540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies.
    Xie F; Kovic B; Jin X; He X; Wang M; Silvestre C
    Pharmacoeconomics; 2016 Nov; 34(11):1087-1100. PubMed ID: 27339668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.